# Bestudy

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bestudy

- Industry: Pharmaceuticals
- Headquarters: Shanghai, China
- Website: www.bestudycro.com
- Total disclosed funding: $15M
- Latest round: Series B (Sep 23, 2020)
- Investors on record: 6

## About

Established in 2010 and based in Shanghai, China, Bestudy is a medicine company that focuses on clinical drug development. It has been working on projects with over 400 hospitals in more than 30 provinces and 86 cities and established partnerships with Baxter, Bayer, and other companies. The branch offices have been set up in Beijing, Guangzhou, Chengdu, and other places. In September 2020, it raised series B funding for CNY 100 million. In 2021, Bestudy was selected as a Specialized, Refined, Featured, and Original SME in Shanghai.

The company is committed to providing clinical research services to domestic and foreign pharmaceutical and medical equipment enterprises such as registration and application, protocol writing, site screening, clinical monitoring services, and so on for Phase I-IV drug clinical trials and medical device clinical trials. It has participated in the registration and application, clinical design, and project management of over 80 new drugs, and undertook over 500 registered clinical research projects for phases I-III.

## Funding rounds

- Series B, Sep 23, 2020, $15M — Loyal Valley Capital, Huaige Capital, Ennovation Ventures, GL Ventures, Ruihe Xingye Asset
- Series A, Apr 8, 2018 — CCB Private Equity Investment Management, Huaige Capital

## Investors

- CCB Private Equity Investment Management (https://capitalatlas.ai/funds/ccb-private-equity-investment-management) — Series A
- Huaige Capital (https://capitalatlas.ai/funds/huaige-capital) — Series A, Series B
- Loyal Valley Capital (https://capitalatlas.ai/funds/loyal-valley-capital) — Series B
- Ennovation Ventures (https://capitalatlas.ai/funds/ennovation-ventures) — Series B
- GL Ventures (https://capitalatlas.ai/funds/gl-ventures) — Series B
- Ruihe Xingye Asset (https://capitalatlas.ai/funds/ruihe-xingye-asset) — Series B